Immunotherapy of Cancer
Antigen specific cytotoxic T lymphocytes (CTL) are being studied for their potential immunotherapeutic benefit in the treatment of cancer. Carcinoembryonic antigen (CEA) is an oncofetal protein best known for its overexpression in the majority of colorectal, gastric, pancreatic, non small cell lung, and breast carcinomas. We are using dendritic cells (DC) pulsed with the CEA CTL peptide epitope to generate CEA specific CTL. DC from HLA A2+ donors were isolated by culturing plastic adherent PBMC in GMCSF and 1L4 for 7 days. As expected these DC expressed the relevant cell surface molecules including HLA DR, CD58, CD80, and CD86. The DC were strippped of their endogenous peptides, pulsed with the A2 restricted CEA peptide, irradiated and used to stimulate autologous CD8+ T cells in the presence of 1L7. Using this approach we have been able to generate CEA specific CTL from the PBMC of breast and pancreatic carcinoma patients as well as normal donors. These CTL can lyse CEA peptide pulsed T2 targets as well as HLA A2+ tumor cells expressing the CEA antigen. This data is being used to support a phase I active immunotherapy clinical protocol using DC pulsed with CEA peptide to treat patients with metastatic malignancies expressing CEA.
KeywordsDendritic Cell Peptide Pulse Dendritic Cell Pulse Dendritic Cell Oncofetal Protein Pancreatic Carcinoma Patient
Unable to display preview. Download preview PDF.
- 2.Rosenberg, S.A. Immunotherapy of cancer using interleukin-2: Current status and future prospects. Immunol. Today 9, 58–62 (1988).Google Scholar
- 5.Tsang, K. Y., et al. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl. Canc. Ins. 87, 982990 (1995).Google Scholar
- 7.Mehta, D.A., Markowicz, S., and Engleman, E.G. Generation of antigen-specific CD8’ CTLs from naive precursors. J. Immunol. 153 996–1003(1994).Google Scholar
- 9.Mehta, D.A., Markowicz, S., and Engleman, E.G. Generation of antigen-specific CD4` T cell lines from naive precursors. Eur. J. Immunol. 25, 206–1211 (1995).Google Scholar
- 10.Mayordomo, J.1., et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1(12), 1297–1302 (1995).Google Scholar
- 15.Bakker, A. B., et. al. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55, 5330–5334 (1995).Google Scholar